Impact of serological and PCR testing requirements on the selection of COVID‐19 convalescent plasma donors

BACKGROUND: Convalescent plasma is undergoing randomized trials as a potential therapeutic option for COVID‐19 infection. Little empirical evidence exists regarding the determination of donor eligibility and experiences with donor selection. STUDY DESIGN AND METHODS: This prospective study was condu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transfusion
Autors principals: Carter, Jason A., Freedenberg, Alex T., Romeiser, Jamie L., Talbot, Lillian R., Browne, Nicholas J., Cosgrove, Megan E., Shevik, Margaret E., Generale, Laura M., Rago, Molly G., Caravella, Giuseppina A., Ahmed, Tahmeena, Mamone, Linda J., Bennett‐Guerrero, Elliott
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2021
Matèries:
Blood Donors and Blood Collection
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8013201/
https://ncbi.nlm.nih.gov/pubmed/33559248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.16293
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars